Abstract
Objective: Our objective was to evaluate the efficacy of Synthetic Serum Substitute (Irvine Scientific—Materials Section, Santa Ana, CA), a globulin-enriched protein preparation containing human serum albumin for supplementation of IVF culture media.
Design: We retrospectively analyzed IVF cycles performed at MacDonald Womens Hospital between January 1992 and November 1994. IVF cycles were reviewed and classified according to the nature of protein supplementation used in the embryo culture medium. Three protein supplements utilized during this time period were compared: Synthetic Serum Substitute (SSS), Plasmanate (PL), and maternal serum (MS).
Results: Although clinical pregnancy rates among the three treatment groups were not statistically different, there was a definite trend toward a higher pregnancy rate with SSS supplementation (SSS, 38.2%; MS, 28.0%; and PL, 24.9%). Embryos grown in SSS-supplemented culture media had a significantly higher implantation rate (17.8 vs 10.4 and 10.3%, respectively, for MS and PL). Preliminary data also suggest that human embryo development and blastulation in vitro were enhanced by this protein supplement.
Conclusions: The higher implantation rate with SSS suggests that it may be superior to both maternal serum and Plasmanate in supporting human embryo development in vitro. Whether blastocysts derived from PL- and SSS-supplemented media are able to implant and give rise to clinical pregnancies remains to be seen.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Ashwood-Smith MJ, Hollands P, Edwards RG: The use of Albuminar (TM) as a medium supplement in clinical IVF. Hum Reprod 1989;4:702–705
Staessen C, Van den Abbeel E, Khan C, Devroey P, Van Steirtegehen AC: Comparison between human serum and Albumninar-20 (TM) supplement for in vitro fertilization. Hum Reprod 1990;5(3):336–341
de Ziegler D, Cedars MI, Hamilton F, Moreno T, Meldrum DR: Factors influencing maintenance of sperm motility during in vitro processing. Fertil Steril 1987;48:816–820
Caro CM, Trounson A: The effect of protein on preimplantation mouse embryo development in vitro. J Vitro Fert Embryo Transfer 1984;1:183–187
Holst N, Bertheussen K, Forsdahl F, Hakonsen M, Hansen L, Nielsen H: Optimization and simplification of culture conditions in human in vitro fertilization (IVF) and preembryo replacement by serum-free media. J Vitro Fert Embryo Transfer 1990;7(1):47–53
Psalti I, Loumaye E, Pensis M, Depreester S, Thomas K: Evaluation of a sythetic serum substitute to replace fetal cord serum for human oocyte fertilization and embryo growth in vitro. Fertil Steril 1989;52:807–811
Huisman G, Lo-A-Njoe N, Alberda A, Leerentveld R, Verhoeff A, Zeilmaker G: Comparison of results obtained with human serum and a protein solution as a supplement for in vitro fertilization culture medium. Fertil Steril 1992;58:637–639
Adler A, McVicker R, Bedford MJ, Alikani M, Cohen J: Plasmanate as a medium supplement for in vitro fertilization. J Assist Reprod Genet 1993;10:67–71
Pool T, Martin J: High continuing pregnancy rates after in vitro fertilization-embryo transfer using medium supplemented with a plasma protein fraction containing alpha and beta globulins. Fertil Steril 1994;61(4):714–719
Damewood M, Hesla J, Sclaff W, Hubbard M, Gearhart J, Rock J: Effect of serum from patients with minimal to mild endometriosis on mouse embryo development in vitro. Fertil Steril 1990;54:917–920
Dorkas A, Sargent IL, Redman CWG, Barlow DH: Sera from women with unexplained infertility inhibit both mouse and human embryo growth in vitro. Fertil Steril 1993;60:285–292
Oskenberg JR, Brautar C: In vitro suppression of murine blastocyst growth by sera from women with reproductive disorders. Am J Reprod Immunol 1986;11:118–124
Caro CM, Trounson A: Successful fertilization, embryo development, and pregnancy in human in vitro fertilization (IVF) using a chemically defined culture medium containing no protein. J Vitro Fert Embryo Transfer 1986;3:215
Kruger TF, Stander FSH, Smith K, Van der Merwe JP, Lombard CJ: The effect of serum supplementation on the cleavage of human embryos. J Vitro Fert Embryo Transfer 1987;4:10
Pope AK, Harrison KL, Wilson LM, Breen TM, Cummins JM: UltroSerG as a serum substitute in embryo culture medium. J Vitro Fert Embryo Transfer 1987;4:286
McKiernan SH, Bavister BD: Timing of development is a critical parameter for predicting successful embryogenesis. Hum Reprod 1994;9(11):2123–2129
Cummins JM, Breen TM, Harrison KL, Shaw JM, Wilson LM, Hennesey JF: A formula for scoring human embryo growth rates in in vitro fertilization: Its value in predicting pregnancy and in comparison with visual estimates of embryo quality. J Vitro Fertil Embryo Transfer 1986;3:284–295
Huisman G, Alberda A, Leerentveld R, Verhoeff A, Zeilmater G: A comparison of in vitro fertilization results after embryo transfer after 2, 3 and 4 days of embryo culture. Fertil Steril 1994;61:970–972
Dorkas A, Sargent IL, Gardner RL, Barlow DH, Ross C: The human blastocyst: Morphology and human chorionic gonadotrophin secretion in vitro. Hum Reprod 1991;6:1143–1151
Hardy K, Handyside AH, Winston RK: The human blastocyst: Cell number, death and allocation during late preimplantation development in vitro. Development 1989;107:597–604
Lopata A: The neglected human blastocyst. J Assist Reprod Genet 1992;9:508–512
Croxatto NB, Funtealba B, Diaz S, Pastene L, Tatum HJ: A simple nonsurgical technique to obtain unemplanted eggs from human uteri. Am J Obstet Gynecol 1972;112:662–665
Braude P, Bolton V, Moore S: Human gene expression first occurs between the four- and eight-cell of preimplantion development. Nature 1988;332:459–461
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Desai, N.N., Sheean, L.A., Martin, D. et al. Clinical experience with synthetic serum substitute as a protein supplement in IVF culture media: A retrospective study. J Assist Reprod Genet 13, 23–31 (1996). https://doi.org/10.1007/BF02068865
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02068865